BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting
Hexnode Unveils Hexnode Synapse, Bringing Agentic Orchestration To IT And Security Operations
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction
CAMBRIDGE, Mass. and NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
HOUSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in…
Company to host conference call and webcast Thursday, October 7, 2021, at 9:00 a.m. ET…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
Management to host webcast and conference call on October 7 at 8 a.m. ET SAN…
The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnate’s lead RAF inhibitor candidate…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company…
Cloud-based and validated regulatory software automates and advances quality of patient narratives PRINCETON, N.J., Sept….
PHILADELPHIA, Sept. 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
NEW HAVEN, Conn., Sept. 30, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
– Late-breaking oral presentation will feature a comprehensive review of 58-week results from the company’s Phase…
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION FOR THE FIRST…
Infant Bacterial Therapeutics (IBT) announces that the company has reached the next important milestone after…
Dosing of first patient in the expansion phase triggers a milestone payment of €8 million…
CORAL GABLES, Fla., Sept. 30, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX),…
Healthcare technology and patient solutions provider received high marks for 15 culture drivers to rank…
Results further support the efficacy and safety profile of pegcetacoplan, an investigational, targeted C3 therapy,…
Saint-Herblain (France), September 30, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…